Table 3 Cell viability % of ME, HF, CF, and EF against MCF-7, HEPG-2, and SW620
Cell line | MCF-7 viability % | HEPG-2 viability % | SW620 viability % | |||
|---|---|---|---|---|---|---|
Conc. | 10 µg/ml | 100 µg/ml | 10 µg/ml | 100 µg/ml | 10 µg/ml | 100 µg/ml |
ME | 83.52 ± 0.59 | 54.16 ± 1.04 | 82.19 ± 0.15 | 46.30 ± 1.89 | 95.99 ± 0.5 | 74.40 ± 0.66 |
HF | 75.16 ± 0.71 | 1.97 ± 0.17 | 48.39 ± 1.37 | 6.85 ± 0.35 | 97.31 ± 0.37 | 0.79 ± 0.22 |
CF | 80.08 ± 0.54 | 2.42 ± 0.22 | 78.97 ± 1.5 | 4.98 ± 1.32 | 99.49 ± 0.22 | 0.38 ± 0.02 |
EF | 97.72 ± 0.52 | 84.03 ± 0.41 | 96.42 ± 1.21 | 94.70 ± 0.28 | 97.041 ± 1.3 | 93.34 ± 0.14 |
Negative control | 100 | 100 | 100 | |||